FI884057A - Menetelmä diltiatseemia sisältävän luovutuslaitteen valmistamiseksi - Google Patents

Menetelmä diltiatseemia sisältävän luovutuslaitteen valmistamiseksi Download PDF

Info

Publication number
FI884057A
FI884057A FI884057A FI884057A FI884057A FI 884057 A FI884057 A FI 884057A FI 884057 A FI884057 A FI 884057A FI 884057 A FI884057 A FI 884057A FI 884057 A FI884057 A FI 884057A
Authority
FI
Finland
Prior art keywords
preparing
delivery device
device containing
containing diltiazem
diltiazem
Prior art date
Application number
FI884057A
Other languages
English (en)
Swedish (sv)
Other versions
FI884057A0 (fi
FI92553B (fi
FI92553C (fi
Inventor
George V Guittard
Patrick S-L Wong
Fleix Theeuwes
Richard Cortese
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI884057A0 publication Critical patent/FI884057A0/fi
Publication of FI884057A publication Critical patent/FI884057A/fi
Publication of FI92553B publication Critical patent/FI92553B/fi
Application granted granted Critical
Publication of FI92553C publication Critical patent/FI92553C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI884057A 1988-06-02 1988-09-02 Menetelmä diltiatseemia sisältävän luovutuslaitteen valmistamiseksi FI92553C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20151988 1988-06-02
US07/201,519 US4859470A (en) 1988-06-02 1988-06-02 Dosage form for delivering diltiazem

Publications (4)

Publication Number Publication Date
FI884057A0 FI884057A0 (fi) 1988-09-02
FI884057A true FI884057A (fi) 1989-12-03
FI92553B FI92553B (fi) 1994-08-31
FI92553C FI92553C (fi) 1994-12-12

Family

ID=22746162

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884057A FI92553C (fi) 1988-06-02 1988-09-02 Menetelmä diltiatseemia sisältävän luovutuslaitteen valmistamiseksi

Country Status (25)

Country Link
US (1) US4859470A (fi)
JP (1) JP2590226B2 (fi)
KR (1) KR960006062B1 (fi)
AR (1) AR241635A1 (fi)
AT (1) AT394311B (fi)
AU (1) AU612398B2 (fi)
BE (1) BE1001935A3 (fi)
CA (1) CA1311687C (fi)
CH (1) CH675208A5 (fi)
DE (1) DE3829941C2 (fi)
DK (1) DK175396B1 (fi)
ES (1) ES2008813A6 (fi)
FI (1) FI92553C (fi)
FR (1) FR2632306B1 (fi)
GB (1) GB2219205B (fi)
GR (1) GR1000197B (fi)
IE (1) IE61861B1 (fi)
IT (1) IT1223799B (fi)
LU (1) LU87327A1 (fi)
MX (1) MX174157B (fi)
NL (1) NL194747C (fi)
NO (1) NO174766C (fi)
PT (1) PT88405B (fi)
SE (1) SE503508C2 (fi)
ZA (1) ZA886436B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
EP1205190B1 (en) * 1999-08-04 2006-05-03 Astellas Pharma Inc. Stable medicinal compositions for oral use using ferric oxides
US6562375B1 (en) 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
CA2576386A1 (en) 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
PL1789021T3 (pl) 2004-08-13 2012-04-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
EP0271438B1 (de) * 1986-11-14 1992-04-29 Ciba-Geigy Ag Orales osmotisches System für Metoprolol mit verbesserten Formulierungseigenschaften

Also Published As

Publication number Publication date
NO174766B (no) 1994-03-28
AU612398B2 (en) 1991-07-11
AU2152788A (en) 1989-12-07
FR2632306A1 (fr) 1989-12-08
DK175396B1 (da) 2004-09-27
AR241635A1 (es) 1992-10-30
FI884057A0 (fi) 1988-09-02
KR960006062B1 (ko) 1996-05-08
NO174766C (no) 1994-07-06
LU87327A1 (fr) 1989-03-08
FI92553B (fi) 1994-08-31
DE3829941C2 (de) 1997-07-03
IT8867791A0 (it) 1988-09-02
DK485688A (da) 1989-12-03
KR900000076A (ko) 1990-01-30
GR1000197B (el) 1992-03-20
ATA214588A (de) 1991-09-15
IE61861B1 (en) 1994-11-30
US4859470A (en) 1989-08-22
GR880100574A (en) 1990-05-11
FI92553C (fi) 1994-12-12
DE3829941A1 (de) 1989-12-14
MX174157B (es) 1994-04-25
GB2219205B (en) 1992-07-15
ZA886436B (en) 1989-05-30
NL8802181A (nl) 1990-01-02
NO883838D0 (no) 1988-08-29
PT88405A (pt) 1990-06-29
NL194747C (nl) 2003-02-04
BE1001935A3 (fr) 1990-04-17
GB2219205A (en) 1989-12-06
SE503508C2 (sv) 1996-06-24
FR2632306B1 (fr) 1990-11-16
IT1223799B (it) 1990-09-29
AT394311B (de) 1992-03-10
DK485688D0 (da) 1988-09-01
JPH01313432A (ja) 1989-12-18
NO883838L (no) 1989-12-04
SE8803085D0 (sv) 1988-09-02
NL194747B (nl) 2002-10-01
SE8803085L (sv) 1989-12-03
CH675208A5 (fi) 1990-09-14
ES2008813A6 (es) 1989-08-01
GB8820461D0 (en) 1988-09-28
IE882642L (en) 1989-12-02
CA1311687C (en) 1992-12-22
PT88405B (pt) 1995-07-18
JP2590226B2 (ja) 1997-03-12

Similar Documents

Publication Publication Date Title
FI894342A (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI98192B (fi) Menetelmä ravintoainekoostumuksen valmistamiseksi
FI884057A0 (fi) Menetelmä diltiatseemia sisältävän luovutuslaitteen valmistamiseksi
GB2198711B (en) Carton delivery apparatus
GB2223766B (en) Apparatus for making a yarn
EG19448A (en) Packaging for chemicals
FI97370B (fi) Nesteen jakelulaitteen suutinrakenne
FI884526A (fi) Menetelmä isradipiinia luovuttavan annosmuodon valmistamiseksi
NO173492C (no) Snepplaasanordning for en beholder
FI955646A0 (fi) Ligandeja FLT3-reseptoreita varten
FI893938A0 (fi) Järjestelmä rungon analysoimiseksi
EP0344417A3 (en) Conveying device for bottles
EP0266716A3 (en) A transfusion apparatus
FI881882A (fi) Välineistö hammasproteesin kiinnittämiseksi
NO893907D0 (no) Konnektor for en beholder for farmasoeytiske loesninger.
FI954241A0 (fi) Puolijohdelaitteen valmistusmenetelmä
GB2220396B (en) A conveying apparatus
AR244898A1 (es) Aparato de manejo para una disposicion multiprocesadora.
NO175994C (no) Utmatningsanordning for et filament
FI882796A0 (fi) Neljän pullon ympärille asetettava kantopakkaus
GB2188309B (en) A bottle washing-sterilizing apparatus
EP0264246A3 (en) Cleaning device for a container
EP0270381A3 (en) A semiconductor light-emitting apparatus
IT1231796B (it) Dispositivo trasportatore per un serbatoio collettore
GB2226185B (en) A light emitting apparatus

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: ALZA CORPORATION

MA Patent expired